Kinomic profiling of tumour xenografts derived from patients with non–small cell lung cancer confirms their fidelity and reveals potentially actionable pathways.

MLA

Tabbò, Fabrizio, et al. “Kinomic Profiling of Tumour Xenografts Derived from Patients with Non–small Cell Lung Cancer Confirms Their Fidelity and Reveals Potentially Actionable Pathways.” European Journal of Cancer, vol. 144, Feb. 2021, pp. 17–30. EBSCOhost, https://doi.org/10.1016/j.ejca.2020.10.036.

APA

Tabbò, F., Guerrera, F., van den Berg, A., Gaudiano, M., Maletta, F., Bessone, L., Nottegar, A., Costardi, L., de Wijn, R., Ruijtenbeek, R., Delsedime, L., Sapino, A., Ruffini, E., Hilhorst, R., & Inghirami, G. (2021). Kinomic profiling of tumour xenografts derived from patients with non–small cell lung cancer confirms their fidelity and reveals potentially actionable pathways. European Journal of Cancer, 144, 17–30. https://doi.org/10.1016/j.ejca.2020.10.036

Chicago

Tabbò, Fabrizio, Francesco Guerrera, Adrienne van den Berg, Marcello Gaudiano, Francesca Maletta, Luca Bessone, Alessia Nottegar, et al. 2021. “Kinomic Profiling of Tumour Xenografts Derived from Patients with Non–small Cell Lung Cancer Confirms Their Fidelity and Reveals Potentially Actionable Pathways.” European Journal of Cancer 144 (February): 17–30. doi:10.1016/j.ejca.2020.10.036.